GLP1R-targeting drugs dominate type 2 diabetes pipeline: GlobalData
This indicates a shift from the conventional IR to the GLP1R as the primary target for pioneering T2D treatments
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.